Trials / Terminated
TerminatedNCT00714883
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
A Prospective, Multi-Center Study of the Conor Cobalt Chromium Reservoir Based Stent (NevoTM) With Sirolimus Elution in Native Coronary Artery Lesions (NEVO RES-II)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the target lesion failure rate of the NEVO Sirolimus-eluting Coronary Stent System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NEVO™ Sirolimus-eluting Coronary Stent System | Intervention will consist of percutaneous coronary intervention for treatment of lesions in native coronary arteries using standard coronary intervention techniques. Intervention will include treatment with the NEVO™ Sirolimus-eluting Coronary Stent System. |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-11-01
- Completion
- 2012-10-01
- First posted
- 2008-07-14
- Last updated
- 2012-10-25
Locations
2 sites across 2 countries: Germany, Latvia
Source: ClinicalTrials.gov record NCT00714883. Inclusion in this directory is not an endorsement.